wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38792704-42090C28-8975-4279-9F58-115A28FC33D9
Q38792704-42090C28-8975-4279-9F58-115A28FC33D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38792704-42090C28-8975-4279-9F58-115A28FC33D9
Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial.
P2860
Q38792704-42090C28-8975-4279-9F58-115A28FC33D9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38792704-42090C28-8975-4279-9F58-115A28FC33D9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8234104ecce8d26d0bb3b9f7a007d68b72696729
P2860
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.